Dysplastic nevi are a risk factor for uveal melanoma

European Journal of Ophthalmology

Volumn 6, Issue 4, 1996, Pages 472-474

  Hammer, H ^a,b   Olah J ^a   Toth Molnar E ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b NONE   (Hungary)

Author keywords

Atypical moles; Dysplastic nevus; Risk factor; Uveal melanoma

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DYSPLASTIC NEVUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; UVEA MELANOMA;

DYSPLASTIC NEVUS SYNDROME; FEMALE; HUMANS; HUNGARY; MALE; MELANOMA; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SKIN NEOPLASMS; UVEAL NEOPLASMS;

EID: 0030476566     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067219600600423     Document Type: Article

References (15)

1. Kang S, Barnhill RL, Mihm MC J, Fitzpatrick TB, Sober AJ. Melanoma risk in individuals with clinically atypical nevi. Arch Dermatol 1994; 130: 999-1001.
2. Greene MH, Clark WH, Tucker MA, et al. Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med 1985; 312: 91-7.
3. McCarthy JM, Rootman J, Horsman D, et al. Conjunctival and uveal melanoma in the dysplastic nevus syndrome. Surv Ophthalmol 1993; 37: 377-86.
4. Sober AJ, Kang S, Barnhill RL. Discerning individuals at elevated risk for cutaneous melanoma. Clin Dermatol 1992; 10: 15-20.
5. Tucker MA, Shields JA, Hartge P, et al. Sunlight exposure as a risk factor for intraocular malignant melanoma. N Engl J Med 1985; 313: 789-92.
6. Skolnick M. Cancer incidence in defined populations. In: Cairns J, Lyon JL, Skolnick M, eds. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory, 1980; 285-97.
7. Greene MH, Fraumeni JF. The hereditary variant of malignant melanoma. In: Clark WH, Goldman L, Mastrangelo M, eds. Human malignant melanoma. New York: Grune and Stratton, 1979; 139-66.
8. Piepkorn MW. Genetic basis of susceptibility to melanoma. J Am Acad Derm 1994; 31: 1022-39.
9. Bale SJ, Chakravanti A, Greene MH. Cutaneous malignant melanoma and familial dysplastic nevus: evidence for autosomal dominance and pleiotropy. Am J Hum Genet 1986; 38: 188-96.
10. Goldstein AM, Dracopoli NC, Engelstem M, et al. Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogenity. Am J Hum Genet 1994; 54: 489-96.
11. Bale SJ, Dracopoli NC, Tucker MA, et al. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med 1989; 320: 1367-72.
12. Cannon-Albright LA, Goldgar DE, Meyer LJ, et al. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-22. Science 1992; 258: 1148-52.
13. Slade J, Marghoob AA, Salopek TG, Rigel DS, Kopf AW, Bart RS. Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management J Am Acad Derm 1995; 32: 479-94.
14. Trent JM, Stanbridge EJ, McBridge HL, et al. Tumorigenicity in human melanoma cell lines controlled by human chromosome 6. Science 1990; 247: 568-71.
15. van Hees CLM, de Boer A, Jager MJ, et al. Are atypical nevi a risk factor for uveal melanoma? A case-control study. J Invest Derm 1994; 103: 202-5.